AKT1 and colorectal carcinoma: Other studies have also reported potent antitumorigenic effects for metformin against CRC that were portrayed by cell cycle arrest, increased apoptosis, and downregulations in the PI3K/Akt/mTOR network [24,25,26,27,28].